RACHEL KISNONSKY: Open Payments
NPI 1407609589 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,945 in 117 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $892 · 2025 $2,945
Food & beverage: $2,440Education: $505
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $240 |
| Merck Sharp & Dohme LLC | 8 | $214 |
| Novartis Pharmaceuticals Corporation | 11 | $187 |
| SEAGEN INC. | 2 | $184 |
| Daiichi Sankyo Inc. | 9 | $181 |
| Incyte Corporation | 4 | $155 |
| PFIZER INC. | 9 | $134 |
| BeOne Medicines USA, Inc. | 4 | $110 |
| ARRAY BIOPHARMA INC | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
Products named: KEYTRUDA, Enhertu, XTANDI, BRUKINSA, Onivyde, OPDIVO, Fabhalta, Trodelvy.
Industry payments across MI — which companies pay providers there.
